Treatment Considerations in MCL – Oncology – Clinical Care Options

mantle cellA good piece comparing some of the recent evidence for more or less intensive treatment regimes for older MCL patients (between 60 and 70). Treatment intensity (and toxicity) ranges from R Hyper CVAD and auto SCT (which I had), R-CHOP with auto SCT, to lesser intensity regimes such as R-CHOP and Rituximab maintenance and new drugs like Bendamustine.

Similar to some of the more recent practices at MD Anderson (see Mantle cell lymphoma: a non-Hodgkin’s lymphoma).

Treatment Considerations in MCL – Oncology – Clinical Care Options.

Advertisements

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s